BBD
Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy. Br J Haematology 2017 PMID: 28169430, DOI: 10.1111/bjh.1453…
Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy. Br J Haematology 2017 PMID: 28169430, DOI: 10.1111/bjh.1453…